TECH.NASDAQBio-techne CORP

Form 4: Bio-Techne Corp: CEO Kim Kelderman Reports Changes in Beneficial Ownership

Sentiment:

SEC Filing

📋All filings for Bio-techne CORP
🔒Login to Follow

CEO Kim Kelderman reports changes in beneficial ownership of Bio-Techne Corp shares, including stock options and restricted stock units, as per a Form 4 filing with the SEC.

Summary

  • Kim Kelderman, CEO of Bio-Techne Corp, filed a Form 4 with the SEC detailing changes in beneficial ownership.
  • The report includes transactions related to common stock, stock options, and performance-based restricted stock units.
  • Kelderman directly owns 39,942 shares of common stock.
  • The filing details various stock options with exercise prices ranging from $37.7 to $120.46, expiring between 2025 and 2034.
  • The filing also details performance restricted stock units that vest based on achievement of certain performance goals.
  • The transactions reported occurred on August 15, 2024.
  • The filing was signed by Andrew Nick, Attorney-in-Fact for Kim Kelderman, on August 19, 2024.

Sentiment

Score: 5

Explanation: Neutral sentiment as it is a standard regulatory filing detailing changes in ownership. No inherent positive or negative implications.

Positives

  • The filing provides transparency into the CEO's holdings and transactions.
  • The vesting schedules for stock options and restricted stock units are detailed.

Future Outlook

The document does not contain specific forward-looking statements beyond the vesting schedules of the stock options and restricted stock units.

Industry Context

Form 4 filings are standard practice for reporting changes in beneficial ownership by company insiders, providing transparency to investors.

Comparison to Industry Standards

  • Executive compensation packages often include stock options and restricted stock units to align management's interests with shareholders.
  • Vesting schedules are common and designed to incentivize long-term performance.
  • The specific terms of these equity grants (exercise prices, vesting dates, performance conditions) are typical for executive compensation in publicly traded companies.

Stakeholder Impact

  • Shareholders gain insight into the CEO's holdings and incentives.
  • Employees may be indirectly affected by the CEO's incentives to improve company performance.

Key Dates

DateDescription
08/06/2022Options to purchase 6,484 shares vest.
08/15/2023Options to purchase 7,236 shares vest.
08/06/2023Options to purchase 6,484 shares vest.
08/15/2024Earliest transaction date; Options to purchase 7,348 shares vest; Options to purchase 7,236 shares vest; Options to purchase 69,061 shares vest; Performance Restricted Stock Units vest; Restricted Stock Units vest.
11/01/2024Options to purchase 9,563 shares vest.
02/01/2025Options to purchase 12,973 shares vest.
05/01/2025Stock Option (Right to Buy) Expiration Date.
08/15/2025Performance Restricted Stock Units vest; Options to purchase 7,348 shares vest; Options to purchase 7,232 shares vest; Options to purchase 17,265 shares vest; 8,543 restricted stock units vest.
08/08/2025Stock Option (Right to Buy) Expiration Date.
11/01/2025Options to purchase 9,563 shares vest.
02/01/2026Options to purchase 12,972 shares vest.
08/15/2026Performance Restricted Stock Units vest; Options to purchase 7,236 shares vest; Options to purchase 7,347 shares vest; Options to purchase 17,265 shares vest; 8,543 restricted stock units vest.
11/01/2026Options to purchase 9,563 shares vest.
02/01/2027Options to purchase 12,973 shares vest.
08/07/2026Stock Option (Right to Buy) Expiration Date.
08/15/2027Performance Restricted Stock Units vest; Options to purchase 7,348 shares vest; Options to purchase 17,265 shares vest; 8,544 restricted stock units vest.
08/05/2027Stock Option (Right to Buy) Expiration Date.
11/01/2027Options to purchase 9,563 shares vest.
02/01/2028Options to purchase 12,972 shares vest.
08/06/2028Stock Option (Right to Buy) Expiration Date; Options to purchase 17,266 shares vest.
08/15/2029Performance Stock Options (Right to Buy) Expiration Date; Stock Options (Right to Buy) Expiration Date.
08/15/2030Performance Stock Options (Right to Buy) Expiration Date; Stock Options (Right to Buy) Expiration Date.
11/01/2030Stock Options (Right to Buy) Expiration Date.
02/01/2031Performance Stock Options (Right to Buy) Expiration Date; Stock Options (Right to Buy) Expiration Date.
08/15/2034Stock Options (Right to Buy) Expiration Date.
08/19/2024Date of signature by Attorney-in-Fact.

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.